NOVARTIS PHARMACEUTICALS CORPORATION - RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA

PIID: 36C25026N0310

Signed Date: Feb 9, 2026Effective Date: Feb 1, 2026End Date: Closes in 202 days

Award $

$2.4M

Vendor

NOVARTIS PHARMACEUTICALS CORPORATION

NAICS

325412

Signed Date

Feb 9, 2026

Key Details

Dollars Obligated

$2.4M

Base & All Options

$2.4M

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

EAST HANOVER, NJ, 079361810, CD-NJ-11

Description

RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA

Context & Analysis

On Feb 9, 2026, Department of Veterans Affairs obligated $2,423,132.82 to NOVARTIS PHARMACEUTICALS CORPORATION for radiopharmaceuticals pluvicto / lutathera. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in EAST HANOVER, NJ. The contract is scheduled through Dec 31, 2026 — approximately 7 months remaining.